LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population the Hisayama study

Stroke

Volumn 40, Issue 2, 2009, Pages 382-388

  Imamura, Tsuyoshi ^a   Doi, Yasufumi ^b   Arima, Hisatomi ^a   Yonemoto, Koji ^a   Hata, Jun ^a   Kubo, Michiaki ^a   Tanizaki, Yumihiro ^a   Ibayashi, Setsuro ^b   Iida, Mitsuo ^b   Kiyohara, Yutaka ^a,b  

^a Departments of Environmental Medicine   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cholesterol; Epidemiology; Lipoproteins; Risk factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION; PRIORITY JOURNAL; STROKE; AGE; AGED; ANALYSIS OF VARIANCE; BLOOD; CARDIOVASCULAR DISEASE; CLASSIFICATION; COHORT ANALYSIS; CORONARY ARTERY DISEASE; HEALTH SURVEY; HEART INFARCTION; JAPAN; MIDDLE AGED; NOMENCLATURE; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; COHORT STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STROKE; TERMINOLOGY AS TOPIC;

EID: 60549098394     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.529537     Document Type: Article

References (34)

1. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828.
2. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320:904-910.
3. Wannamethee SG, Shaper AG, Ebrahim S. HDL cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke. 2000;31:1882-1888.
4. Ueda K, Hasuo Y, Kiyohara Y, Wada J, Kawano H, Kato I, Fujii I, Yanai T, Omae T, Fujishima M. Intracerebral hemorrhage in a Japanese community, Hisayama:incidence, changing pattern during long-term follow-up, and related factors. Stroke. 1988;19:48-52.
5. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease:the Copenhagen City Heart Study. BMJ. 1994;309:11-15.
6. Konishi M, Iso H, Komachi Y, Iida M, Shimamoto T, Jacobs DR Jr, Terao A, Baba S, Sankai T, Ito M. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries:the Akita Pathology Study. Stroke. 1993;24:954-964.
7. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, Kagamimori S, Nakagawa H. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women:the Oyabe Study. Stroke. 2003;34:863-868.
8. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment:prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278.
9. Briel M, Studer M, Glass TR, Bucher HC. Effects of statins on stroke prevention in patients with and without coronary heart disease:a metaanalysis of randomized controlled trials. Am J Med. 2004;117:596-606.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
11. National Institute of Neurological Disorders and Stroke Ad Hoc Committee. Classification of cerebrovascular diseases III. Stroke. 1990;21:637-676.
12. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke:definitions for use in a multicenter clinical trial:TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
13. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol. 1986;43:71-84.
14. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M. Incidence and risk factors for subtypes of cerebral infarction in a general population:the Hisayama Study. Stroke. 2000;31:2616-2622.
15. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community:the Hisayama Study. Stroke. 2003;34:2349-2354.
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
17. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr. 2002;11 (suppl 8):S732-S737.
18. Psaty BM, Anderson M, Kronmal RA, Tracy RP, Orchard T, Fried LP, Lumley T, Robbins J, Burke G, Newman AB, Furberg CD. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality:the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52:1639-1647.
19. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, Sharrett AR. Plasma lipid profile and incident ischemic stroke:the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 2003;34:623-631.
20. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death:the Framingham Study. Arch Intern Med. 1981;141:1128-1131.
21. Adams RJ, Carroll RM, Nichols FT, McNair N, Feldman DS, Feldman EB, Thompson WO. Plasma lipoproteins in cortical versus lacunar infarction. Stroke. 1989;20:448-452.
22. Lindgren A, Nilsson-Ehle P, Norrving B, Johansson BB. Plasma lipids and lipoproteins in subtypes of stroke. Acta Neurol Scand. 1992;86:572-578.
23. Yasaka M, Yamaguchi T, Shichiri M. Distribution of atherosclerosis and risk factors in atherothrombotic occlusion. Stroke. 1993;24:206-211.
24. Crouse JR, Goldbourt U, Evans G, Pinsky J, Sharrett AR, Sorlie P, Riley W, Heiss G. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1996;27:69-75.
25. Amarenco P, Labreuche J, Elbaz A, Touboul PJ, Driss F, Jaillard A, Bruckert E. Blood lipids in brain infarction subtypes. Cerebrovasc Dis. 2006;22:101-108.
26. Fisher CM. Lacunar strokes and infarcts:a review. Neurology. 1982;32:871-876.
27. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455-2461.
28. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study):a prospective randomised controlled trial. Lancet. 2006;368:1155-1163.
29. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS):a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-1098.
30. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure:a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829-1839.
31. Kiyohara Y, Ueda K, Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens. 1990;8(suppl):S9-S15.
32. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima H. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis. 2007;190:216-223.
33. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Rahman M, Arima H, Tsuryuya K, Iida M, Kiyohara Y. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population:the Hisayama Study. Stroke. 2007;38:2063-2069.
34. Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C. Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease:a population-based study. Atherosclerosis. 2006;189:369-374.